More consensus needed for OTC 'morning-after' pill sales: TFDA

Taipei, Oct. 23 (CNA) Taiwan Food and Drug Administration (TFDA) said Wednesday that that approving over-the-counter sales of emergency contraception pills "needs consensus" from the public due to its wide social impact.

The agency made the comments in response to a query from CNA, following the recent decision to approve such sales by regulators in Japan.

On Oct. 20, Aska Pharmaceutical announced that its emergency contraceptive Norleveo was approved for over-the-counter sales. According to Japanese media reports, the drug is expected to become available without a prescription or parental consent later this year, though those who purchase it will need to take it in the presence of a licensed pharmacist.

Replying to CNA, TFDA specialist Lin Yi-chu (林意筑) said that such drugs are available by prescription only in Taiwan, and that approving them for over-the-counter use would need further consensus.

Changing their status would involve soliciting input from pharmacists as well as advocacy groups representing women, young people, and parents, Lin said.

The TFDA held two meetings on the subject in March and April, Lin said, adding that the administration would closely monitor Japan's experience and was planning trials "suitable for Taiwan."